You are here

  • Home
  • Archive
  • Volume 27, Issue Suppl 1
  • NP-010 Clinical and pharmacokinetic results after the switch to infliximab biosimilar in inflammatory bowel disease: 2 years of real-life experience

Article metrics

Article menu

Download PDFPDF

National Poster Prize Winners
NP-010 Clinical and pharmacokinetic results after the switch to infliximab biosimilar in inflammatory bowel disease: 2 years of real-life experience
Free

 

Online download statistics by month:

Online download statistics by month: March 2020 to August 2024

AbstractFullPdf
Mar 20201001
Apr 20202808
May 20201202
Jun 20207307
Jul 2020609
Aug 2020204
Sep 20202008
Oct 20202205
Nov 2020403
Dec 20201602
Jan 2021701
Feb 2021402
Mar 20211202
Apr 2021201
May 2021003
Jun 2021001
Jul 2021007
Aug 2021002
Sep 2021002
Oct 20214015
Nov 202112014
Dec 2021805
Jan 2022801
Feb 2022600
Mar 20221600
Apr 20221602
May 2022808
Jun 2022203
Jul 2022600
Aug 2022202
Sep 2022705
Oct 2022403
Nov 2022802
Dec 20221700
Jan 20231203
Feb 20231601
Mar 2023601
Apr 2023201
May 2023801
Jun 2023001
Jul 2023603
Aug 2023002
Sep 2023002
Oct 2023200
Nov 20231003
Dec 2023600
Jan 2024201
Feb 2024602
Mar 20248026
Apr 2024607
May 20241200
Jun 20242800
Jul 2024403
Aug 2024804
Total4840191